ROBERT ANDREW BERMAN Insider Trading
Get free email notifications about insider trading for ROBERT ANDREW BERMAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ROBERT ANDREW BERMAN. ROBERT ANDREW BERMAN is a President & CEO in ITUS Corp ($COPY) and a President and CEO in ITUS Corp ($COPY) and a COO, Gen. Counsel, Sec. in ACACIA RESEARCH CORP ($ACTG/CBMX) and a COO, Gen. Counsel, Sec. in ACACIA RESEARCH CORP ($ACTG/CBMX) and a Exec. V.P., Gen. Counsel, Sec. in ACACIA RESEARCH CORP ($ACTG/CBMX) and a CEO in Hancock Jaffe Laboratories, Inc. ($HJLI) and an Chief Executive Officer in Hancock Jaffe Laboratories, Inc. ($HJLI).
Address: 500 NEWPORT CENTER DRIVE 7TH FLOOR NEWPORT BEACH 92660 CA
Companies in which ROBERT ANDREW BERMAN is an Insider
ACACIA RESEARCH CORP
Trading Symbol: ACTG/CBMXIndustry: PATENT OWNERS & LESSORS [6794]
Position of ROBERT ANDREW BERMAN: COO, Gen. Counsel, Sec., COO, Gen. Counsel, Sec., Exec. V.P., Gen. Counsel, Sec.
Holdings: 0 shares
Latest Transaction: May 03 2006
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Anixa Biosciences Inc
Trading Symbol: COPYIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ROBERT ANDREW BERMAN: President & CEO, President and CEO
Holdings: 51,653 shares
Latest Transaction: Jun 05 2017
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Hancock Jaffe Laboratories, Inc.
Trading Symbol: HJLIIndustry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of ROBERT ANDREW BERMAN: CEO, Chief Executive Officer
Holdings: 21,740 shares
Latest Transaction: Feb 22 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of ROBERT ANDREW BERMAN
Sentiment: All, ACTG/CBMX, COPY, HJLI
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 22 2021 | HJLI | Hancock Jaffe Labo ... | BERMAN ROBERT ANDREW | Chief Executive Off ... | Option Exercise | A | 8.20 | 838,000 | 6,871,600 | 838,000 | |
Jul 21 2020 | HJLI | Hancock Jaffe Labo ... | BERMAN ROBERT ANDREW | CEO | Option Exercise | A | 0.40 | 1,080,207 | 432,083 | 1,080,207 | |
Jul 21 2020 | HJLI | Hancock Jaffe Labo ... | BERMAN ROBERT ANDREW | CEO | Option Exercise | J | 4.99 | 1,080,207 | 5,390,233 | 0 | |
Jul 21 2020 | HJLI | Hancock Jaffe Labo ... | BERMAN ROBERT ANDREW | CEO | Option Exercise | A | 0.40 | 1,000,000 | 400,000 | 1,000,000 | |
Mar 14 2019 | HJLI | Hancock Jaffe Labo ... | BERMAN ROBERT ANDREW | Chief Executive Off ... | Buy | P | 1.15 | 21,740 | 25,001 | 21,740 | 0 to 21.7 K |
Sep 26 2018 | HJLI | Hancock Jaffe Labo ... | BERMAN ROBERT ANDREW | Chief Executive Off ... | Option Exercise | A | 4.99 | 1,080,207 | 5,390,233 | 1,080,207 | |
Jun 05 2017 | COPY | ITUS Corp | BERMAN ROBERT ANDREW | President & CEO | Buy | P | 0.88 | 9,900 | 8,712 | 61,553 | 51.7 K to 61.6 K (+19.17 %) |